美国FDA于2018年7月9-19日检查了你们位于佛罗里达的ActavisLaboratories FL, Inc.生产场所。 This warning letter summarizes significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. See 21 CFR, parts 2...
Actavis plc appoints new members and announces changes to Board of Directors following close of Forest Laboratories, Inc. acquisition - European Pharmaceutical ReviewForest Laboratories Inc